Homburger advised ADC Therapeutics , a commercial-stage biotechnology company with headquarters in Switzerland, on its USD 60 m private placement of common shares and pre-funded warrants. TCGX led the operation, with further participation from Redmile Group and
Tags :ADC Therapeutics
Homburger advised ADC Therapeutics on its USD 100 m Private Placement of Common Shares and Pre-Funded Warrants. The context Headquartered in Switzerland and listed on the NYSE under the ticker ADCT, ADC Therapeutics is a commercial-stage
Homburger advised ADC Therapeutics, a commercial-stage biotechnology company producing antibody drug conjugates (ADCs) for cancer patients, on its 13.4 m of common shares, and, to certain investors who so choose in lieu of common shares, pre-funded
